Reports for SANDOZ CANADA INCORPORATED

Company Name
SANDOZ CANADA INCORPORATED

Shortage reports

Actual shortage:

35 (1%)

Anticipated shortage:

9 (0%)

Avoided shortage:

19 (1%)

Resolved:

2320 (97%)

2383

Discontinuation Reports

To be discontinued:

3 (2%)

Discontinued:

131 (96%)

Reversed:

2 (1%)

136

466 (18%)

3 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ VALSARTAN 80MG TABLET Resolved 2020-11-16 2020-12-05 128426
SANDOZ VALSARTAN 160MG TABLET Resolved 2023-01-19 2023-02-09 181733
SANDOZ VALSARTAN 320MG TABLET Resolved 2020-07-06 2020-08-26 119468
SANDOZ VALSARTAN HCT 12.5MG 320MG TABLET Resolved 2019-04-10 2019-05-07 80979
SANDOZ VALSARTAN HCT 25MG 320MG TABLET Resolved 2025-08-18 2025-09-16 265395
SANDOZ VALSARTAN HCT 320MG 25MG TABLET Resolved 2020-07-20 2020-08-17 120644
SANDOZ VALSARTAN HCT 25MG 320MG TABLET Resolved 2022-11-16 2022-11-29 174915
SANDOZ VALSARTAN HCT 12.5MG 320MG TABLET Resolved 2022-11-16 2022-11-29 174912
SANDOZ VALSARTAN HCT 12.5MG 160MG TABLET Resolved 2022-09-21 2022-10-20 169688
SANDOZ VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2019-02-18 2019-03-13 76169
SANDOZ VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Resolved 2019-05-07 2020-01-22 83298
SANDOZ VENLAFAXINE XR 150MG CAPSULE (EXTENDED RELEASE) Resolved 2020-11-04 2020-12-15 127785
SANDOZ VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Resolved 2020-11-04 2020-12-15 127788
SANDOZ VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Resolved 2020-11-04 2020-12-15 127791
SANDOZ VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Resolved 2019-05-07 2020-01-22 83301
SANDOZ VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-06-12 2020-01-22 86402
SANDOZ VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Resolved 2018-10-15 2019-04-17 64189
SANDOZ VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Resolved 2018-10-15 2019-04-17 64192
SANDOZ VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2019-10-15 2020-01-22 96540
SANDOZ VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-10-09 2018-12-18 63514
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ANGIOMAX 250MG POWDER FOR SOLUTION Discontinued 2026-03-16 2026-03-19 280590
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BORTEZOMIB FOR INJECTION SDZ 3.5MG POWDER FOR SOLUTION Discontinued 2026-03-16 2026-03-19 280595
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
KETOROLAC TROMETHAMINE INJECTION USP 30MG SOLUTION LIQUID Discontinued 2025-08-04 2025-08-05 264341
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265

Showing 1 to 20 of 136